Skip to content

CareDx CDNA Total debt

Total debt at other companies

NeoGenomics logo
NeoGenomicsNEO
$66.29M+5.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$39M-6.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$96.73M+82.5%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$409.89M+505%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $24.5M.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's total debt?
CareDx (CDNA) reported total debt of $24.5M in Q1 2026.
How has CareDx's total debt changed year-over-year?
CareDx's total debt decreased by 19.1% year-over-year, from $30.28M to $24.5M.
What is the long-term trend for CareDx's total debt?
Over 5 years (2020 to 2025), CareDx's total debt has grown at a 7.7% compound annual growth rate (CAGR), from $18.1M to $26.19M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.